DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma | MicrobiomeTrials← Back to trialsNCT04334759
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
CompletedPHASE3INTERVENTIONAL
Trial Details
Start: 2021-02-18Est. Completion: 2025-06-20
Enrollment target: 214 participants Locations- University of California San Diego, La Jolla, California, United States
- University of Miami, Miami, Florida, United States
- Moffitt Cancer Center, Tampa, Florida, United States
- Emory University, Atlanta, Georgia, United States
- University of Chicago, Chicago, Illinois, United States
- NorthShore University Health System/Kellogg Cancer Center, Evanston, Illinois, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
- Massaschusetts General Hospital, Boston, Massachusetts, United States
- Dana Farber Cancer Institute, Boston, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States
- Morristown Medical/Atlantic Health, Morristown, New Jersey, United States
- Jersey Shore University Medical Center, Neptune City, New Jersey, United States
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
- Memorial Sloan Kettering, New York, New York, United States
Other microbiome trials you might be interested in
Malignant Pleural Mesothelioma, Advanced
This Phase 1b/2, open-label, multicenter, single-arm study evaluates the safety and efficacy of ivonescimab in combinati…
Shanghai, ChinaEst. completion Nov 30, 2028
Peritoneal Malignant Mesothelioma
This phase II trial compares the usual treatment alone (carboplatin, pemetrexed, and bevacizumab) to using immunotherapy…
Phoenix, United StatesEst. completion Aug 1, 2027
University of Cincinnati, Cincinnati, Ohio, United StatesCleveland Clinic Foundation, Cleveland, Ohio, United StatesThe Ohio State University, Columbus, Ohio, United StatesPenn State Cancer Institute, Hershey, Pennsylvania, United StatesAbramson Cancer Cener at Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United StatesAllegheny Cancer Center, Pittsburgh, Pennsylvania, United StatesUniversity of Texas Southwestern Medical Center, Dallas, Texas, United StatesBaylor College of Medicine, Houston, Texas, United StatesMD Anderson Cancer Center, Houston, Texas, United StatesUniversity of Virginia, Charlottesville, Virginia, United StatesCanberra Hospital, Garran, Australian Capital Territory, AustraliaBlacktown Hospital, Blacktown, New South Wales, AustraliaChris O'Brien Lifehouse, Camperdown, New South Wales, AustraliaCoffs Harbour Health Campus, Coffs Harbour, New South Wales, AustraliaGosford Hospital, Gosford, New South Wales, AustraliaWyong Hospital, Hamlyn Terrace, New South Wales, AustraliaNepean Hospital, Kingswood, New South Wales, AustraliaLiverpool Hospital, Liverpool, New South Wales, AustraliaOrange Health Service, Orange, New South Wales, AustraliaNorthern Cancer Institute (GenesisCare), Saint Leonards, New South Wales, AustraliaCalvary Mater Newcastle, Waratah, New South Wales, AustraliaWestmead Hospital, Westmead, New South Wales, AustraliaIcon Cancer Care Wesley, Auchenflower, Queensland, AustraliaSunshine Coast University Hospital, Birtinya, Queensland, AustraliaIcon Cancer Care Chermside, Chermside, Queensland, AustraliaThe Prince Charles Hospital, Chermside, Queensland, AustraliaTownsville University Hospital, Douglas, Queensland, AustraliaIcon Cancer Care South Brisbane, South Brisbane, Queensland, AustraliaPrincess Alexandra Hospital, Woolloongabba, Queensland, AustraliaFlinders Medical Centre, Bedford Park, South Australia, AustraliaThe Queen Elizabeth Hospital, Woodville South, South Australia, AustraliaRoyal Hobart Hospital, Hobart, Tasmania, AustraliaLaunceston General Hospital, Launceston, Tasmania, AustraliaMonash Health, Clayton, Victoria, AustraliaPeninsula & South Eastern Haematology and Oncology Group, Frankston, Victoria, AustraliaAustin Hospital, Heidelberg, Victoria, AustraliaPeter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaEpworth HealthCare - Richmond, Richmond, Victoria, AustraliaSunshine Hospital (Western Health), Saint Albans, Victoria, AustraliaGoulburn Valley Health, Shepparton, Victoria, AustraliaSir Charles Gairdner Hospital (SCGH), Nedlands, Western Australia, AustraliaAuckland City Hospital, Grafton, Auckland, New ZealandRecruiting
Solid Tumor, AdultColorectal CancerNon Small Cell Lung CancerPancreatic CancerCRCNSCLCPancreas CancerMesotheliomaOvarian CancerOvarian NeoplasmsOvarian CarcinomaMesothelioma, MalignantMesothelioma; LungCancerTriple Negative Breast Cancer (TNBC)Renal Cell Carcinoma (Kidney Cancer)Head and Neck Squamous Cell Carcinoma HNSCC
Objective:
To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by nex…
Gilbert, United StatesEst. completion Dec 2028